Detection of the human Parvovirus B19 in nonimmune hydrops fetalis using immunohistochemistry and nested-PCR in formalin-fixed and paraffin-embedded placenta and fetal tissues

Pathologie Biologie

Volumn 57, Issue 3, 2009, Pages e1-

  Landolsi, H ^a   Yacoubi, M T ^a   Bouslama, L ^b   Lahmar, A ^a   Trabelsi, A ^a   Hmissa, S ^a   Aouni, M ^b   Korbi, S ^a  

^a FARHAT HACHED HOSPITAL   (Tunisia)

^b UNIVERSITY OF MONASTIR   (Tunisia)

Author keywords

Histology; Hydrops fetalis; Immunohistochemistry; Nested PCR; Parvovirus B19

Indexed keywords

FORMALDEHYDE; PARAFFIN; PROTEIN VP2; VIRUS ANTIBODY; VIRUS DNA;

ARTICLE; CELL NUCLEUS INCLUSION BODY; CONTROLLED STUDY; FETUS; FETUS HYDROPS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NONHUMAN; PARVOVIRUS; PLACENTA; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; VIRUS CAPSID; VIRUS DETECTION; VIRUS GENE;

EID: 64949123245     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.patbio.2007.11.001     Document Type: Article

References (59)

1. Cossart Y.E., Field A.M., Cant B., and Widdows D. Parvovirus-like particles in human sera. Lancet 1 (1975) 72-73
2. van Elascker-Niele A.M., and Kross A.C. Human Parvovirus B19: relevance in internal medicine. Neth J Med 54 (1999) 221-230
3. Anderson M.J., Jones S.E., Fisher-Hoch S.P., Lewis E., Hall S.M., Bartlett C.L., et al. Human Parvovirus, the cause of erythema infectiosum (fifth disease)?. Lancet 1 (1983) 1378
4. Anderson M.J., Lewis E., Kidd I.M., Hall S.M., and Cohen B.J. An outbreak of erythema infectiosum associated with human Parvovirus infection. J Hyg (Lond) 93 (1984) 85-93
5. Reid D.M., Reid T.M., Brown T., Rennie J.A., and Eastmond C.J. Human Parvovirus-associated arthritis: a clinical and laboratory description. Lancet 1 (1985) 422-425
6. White D.G., Woolf A.D., Mortimer P.P., Cohen B.J., Blake D.R., and Bacon P.A. Human Parvovirus arthropathy. Lancet 1 (1985) 419-421
7. Pattison J.R., Jones S.E., Hodgson J., David L.R., White J.M., Stroud C.E., et al. Parvovirus infections and hypoplastic crisis in sickle-cell anaemia. Lancet 1 (1981) 664-665
8. Zerbini M., Musiani M., Venturoli S., Gallinella G., Gibellini D., Gentilomi G., et al. Different syndromes associated with B19 Parvovirus viraemia in paediatric patients: report of four cases. Eur J Pediatr 151 (1992) 815-817
9. Naides S.J. Rheumatic manifestations of Parvovirus B19 infection. Rheum Dis Clin North Am 24 (1998) 375-401
10. Van Horn D.K., Mortimer P.P., Young N., and Hanson G.R. Human Parvovirus-associated red cell aplasia in the absence of underlying haemolytic anemia. Am J Pediatr Hematol Oncol 8 (1986) 235-239
11. Cohen B.J., and Bukley M.M. The prevalence of antibody to human Parvovirus B19 in England and wales. J Med Microbiol 25 (1988) 151-153
12. Harger J.H., Adler S.P., Koch W.C., and Harger G.F. Prospective evaluation of 618 pregnant women exposed to Parvovirus B19: risks and symptoms. Obstet Gynecol 91 (1998) 413-420
13. Hemauer A., Gigler A., Searle K., Beckenlehner K., Raab U., Broliden K., et al. Seroprevalence of Parvovirus B19 NS1-specific IgG in B19-infected and uninfected individuals and in infected pregnant women. J Med Virol 60 (2000) 48-55
14. Enders G., and Bibers M. Parvovirus B19 infections in pregnancy. Behring Inst Mitt 85 (1990) 74-78
15. Jensen I.P., Thorsen P., Jeune B., Moller B.R., and Vestergaard B.F. An epidemic of Parvovirus B19 in a population of 3596 pregnant women: a study of sociodemographic and medical risk factors. BJOG 107 (2000) 637-643
16. Koch W.C., and Alder S.P. Human Parvovirus B19 infections in women of childbearing age and within families. Pediatr Infect Dis J 8 (1989) 83-87
17. Valeur-Jensen A.K., Pedersen C.B., Westergaard T., et al. Risk factors for Parvovirus B19 infection in pregnancy. JAMA 281 (1999) 1099-1105
18. Gratacos E., Torres P.J., Vidal J., Antolin E., Costa J., Jimenez de Anta M.T., et al. The incidence of human Parvovirus B19 infection during pregnancy and its impact on perinatal outcome. J Infect Dis 171 (1995) 1360-1363
19. Enders M., Weidner A., Zoellner I., Searle K., and Enders G. Fetal morbidity and mortality after acute human Parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases. Prenat Diagn 24 (2004) 513-518
20. Ferre F., and Garduno F. Detection of human papillomavirus type 6/11, 16, and 18 using the polymerase chain reaction. Cancer cells 7 (1989) 215-218
21. Cubel R.C.N., Garcia A.G.P., Pegado C.S., et al. Human Parvovirus B19 infection and hydrops fetalis in Rio de Janeiro, Brazil. Mem Inst Oswaldo Cruz 91 (1996) 147-151
22. Tolfvenstam T., Papadogiannakis N., Norbeck O., Petersson K., and Broliden K. Frequency of human Parvovirus B19 infection in intrauterine fetal death. Lancet 357 (2001) 1494-1497
23. Anand A., Gray E.S., Brown T., Clewly J.P., and Cohen B.J. Human Parvovirus infection in pregnancy and hydrops fetalis. N Engl J Med 316 (1987) 183-186
24. Morey A.L., Keeling J.W., Porter H.J., and Fleming K.A. Clinical and histopathological features of Parvovirus B19 infection in the human fetus. Br J Obstet Gynaecol 99 (1992) 566-574
25. Brown T., Anand A., Ritchie L.D., Clewley J.P., and Reid T.M. Intrauterine Parvovirus infection associated with hydrops fetalis. Lancet 2 (1984) 1033-1034
26. Knott P.D., Welply G.A., and Anderson M.J. Serolologically proved intrauterine infection with Parvovirus. Br Med J (Clin Res Ed) 289 (1984) 1660
27. Mortimer P.P., Cohen B.J., Buckley M.M., Cradock-Watson J.E., Ridehalgh M.K., Burkhardt F., et al. Human Parvovirus and the fetus. Lancet 2 (1985) 1012
28. Komischke K., Searle K., and Enders G. Maternal serum alpha-fetoprotein and human chorionic gonadotropin in pregnant women with acute Parvovirus B19 infection with and without fetal complications. Prenat Diagn 17 (1997) 1039-1046
29. Rodis J.F., Quinn D.L., Gray Jr. G.W., et al. Management and outcomes of pregnancies complicated by human B19 Parvovirus infection: a prospective study. Am J Obstet Gynecol 163 (1990) 1168-1171
30. Koch W.C., Harger J.H., Barnstein B., and Adler S.P. Serologic and virologic evidence for frequent intrauterine transmission of human Parvovirus B19 with a primary maternal infection during pregnancy. Pediatr Infect Dis J 17 (1998) 489-494
31. Miller E., Fairley C.K., Cohen B.J., and Seng C. Immediate and long-term outcome of human Parvovirus B19 infection in pregnancy. Br J Obstet Gynaecol 105 (1998) 174-178
32. Yaegashi N., Niinuma T., Chisaka H., et al. Serologic study of human Parvovirus B19 infection in pregnancy in Japan. J Infect 38 (1999) 30-35
33. Oliveira S.A., Camacho L.A.B., Pereira A.C.M., et al. Clinical and epidemiological aspects of human Parvovirus B19 infection in an urban area in Brazil (Niterói city area, State of Rio de Janeiro, Brazil). Mem Inst Oswaldo Cruz 97 (2002) 965-970
34. Torok T.J. Parvovirus B19 and human disease. Adv Intern Med 37 (1992) 431-455
35. Public health laboratory service working party on fifth disease: prospective study of human Parvovirus B19 infection in pregnancy. BMJ 1990; 300: 1166-70.
36. Torok T.J. Human Parvovirus B19 infections in pregnancy. Pediatr Infect Dis J 9 (1990) 772-776
37. Jordan J.A., and Deloia J.A. Globoside expression within the human placenta. Placenta 20 (1999) 103-108
38. Takahashi T., Ozawa K., Takahashi K., Okuno Y., Muto Y., and Takaku F.S.S. DNA replication of Parvovirus B19 in a human erythroid leukaemia cell-line (TK-1) in vitro. Arch Virol 131 (1993) 201-208
39. Miyagawa E., Yoshida T., Takahashi H., Yamaguchi K., Nagano T., Kiriyama Y., et al. Infection of the erythroid cell line KU812Ep6 with human Parvovirus B19 and its application to titration of B19 infectivity. J Virol Methods 83 (1999) 45-54
40. Shimomura S., Komatsu N., Frickhofen N., Anderson S., Kajigaya S., and Young N.S. First continuous propagation of B19 Parvovirus in a cell line. Blood 79 (1992) 18-24
41. Von Kaisenberg C.S., and Jonat W. Fetal Parvovirus B19 infection. Ultrasound Obstet Gynecol 18 (2001) 280-288
42. Berry P.J., Gray E.S., Porter H.J., and Burton P.A. Parvovirus infection of the human fetus and newborn. Semin Diagn Pathol 9 (1992) 4-12
43. Butchko A.R., and Jordan J.A. Comparison of three commercially available serologic assays used to detect human Parvovirus B19-specific immunoglobin M (IgM) and IgG antibodies in sera of pregnant women. J Clin Microbiol 42 (2004) 3191-3195
44. Bruu A.L., and Nordbo S.A. Evaluation of five commercial tests for detection of immunoglobulin M antibodies to human Parvovirus B19. J Clin Microbiol 33 (1995) 1363-1365
45. Tolfvenstam T., Ruden U., and Broliden K. Evaluation of serological assays for identification for Parvovirus B19 immunoglobulin M. Clin Diagn Lab Immunol 3 (1996) 147-150
46. Jordan J.A. Diagnosing human Parvovirus B19 infection: guidelines for test selection. Mol Diagn 6 (2001) 307-312
47. Beersma M.F.C., Claas E.C.J., Sopaheluakan T., and Kroes A.C.M. Parvovirus B19 viral loads in relation to VP 1 and VP2 antibody responses in diagnostic blood samples. J Clin Virol 34 (2005) 71-75
48. Moery A.L., O'Neill H.J., Coyle P.V., and Fleming K.A. Immunohistological detection of human Parvovirus B19 in formalin-fixed, paraffin-embedded tissues. J Pathol 166 (1992) 105-108
49. Wright C., Hinchliffe S.A., and Taylor C. Fetal pathology in intrauterine death due to Parvovirus B19 infection. Br J Obstet Gynaecol 103 (1996) 133-136
50. Quemelo P.R.V., Lima D.M., Fonseca B.A.L., and Peres L.C. Detection of Parvovirus B19 infection in formalin-fixed and paraffin-embedded placenta and fetal tissues. Rev Inst Med trop Sao Paulo 49 (2007) 103-107
51. Morey A.L., Porter H.J., Keeling J.W., and Fleming K.A. Nonisotopic in situ hybridisation and immunophenotyping of infected cells in the investigation of human fetal Parvovirus infection. J Clin Pathol 45 (1992) 673-678
52. Zerbini M., Musiani M., Gentilomi G., Venturoli S., Gallinella G., and Morandi R. Comparative evaluation of virological and serological methods in prenatal diagnosis of Parvovirus B19 fetal hydrops. J Clin Microbiol 34 (1996) 603-608
53. Wattre P., Dewilde A., Subtil D., Andreoletti L., and Thirion V. A clinical and epidemiological study of human pavovirus B19 infection in fetal hydrops using PCR Southern blot hybridization and chemiluminescence detection. J Med Virol 54 (1998) 140-144
54. Cassinotti P., Weitz M., and Siegl G. Human Parvovirus B19 infections: routine diagnosis by a new nested polymerase chain reaction assay. J Med Virol 40 (1993) 228-234
55. Carriere C., Boulanger P., and Delsert C. Rapid and sensitive method for the detection of B19 virus DNA using the polymerase chain reaction with nested primers. J Virol Methods 44 (1993) 221-234
56. Norbeck O., Papadogiannakis N., Petersson K., Hirbod T., Broliden K., and Tolfvenstam T. Revised clinical presentation of Parvovirus B19-associated intrauterine fetal death. Clin Infect Dis 35 (2002) 1032-1038
57. Skjoldebrand-Sparre L., Tolfvenstam T., Papadogiannakis N., Wahren B., Broliden K., and Nyman M. Parvovirus B19 infection: association with third-trimester intrauterine fetal death. BJOG 107 (2000) 476-480
58. Lindblom A., Isa A., Norbeck O., Wolf S., Johansson B., Broliden K., et al. Slow clearance of human Parvovirus B19 viremia following acute infection. Clin Infect Dis 41 (2005) 1201-1203
59. Knoll A., Louwen F., Kochanowski B., Plentz A., Stussel J., Beckenlehner K., et al. Parvovirus B19 infection in pregnancy: quantitative viral DNA analysis using a kinetic fluorescence detection system (TaqMan PCR). J Med Virol 67 (2002) 259-266